Interestingly, MAL overexpression in cutaneous T-cell lymphoma was associated with resistance to alpha-interferon therapy [39], and its expression was indicative of poor prognosis in Hodgkin’s lymphoma [40]. This evidence concerns the gene MAL and primary cutaneous T-cell non-Hodgkin lymphoma.